by Summary:
A seemingly strange phenomenon of a smaller dose of the Oxford-AstraZeneca Covid-19 vaccine being more effective than a bigger one is reportedly explained by it first being tested on a younger group.RTPuzzling higher AstraZeneca vaccine efficacy for smaller dosage explained: It was reportedly tested on people only under 56
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
A seemingly strange phenomenon of a smaller dose of the Oxford-AstraZeneca Covid-19 vaccine being more effective than a bigger one is reportedly explained by it first being tested on a younger group.RTPuzzling higher AstraZeneca vaccine efficacy for smaller dosage explained: It was reportedly tested on people only under 56
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Lars Pålsson Syll writes Andreas Cervenka och den svenska bostadsbubblan
Mike Norman writes Trade deficit
Merijn T. Knibbe writes Christmas thoughts about counting the dead in zones of armed conflict.
Lars Pålsson Syll writes Debunking the balanced budget superstition
A seemingly strange phenomenon of a smaller dose of the Oxford-AstraZeneca Covid-19 vaccine being more effective than a bigger one is reportedly explained by it first being tested on a younger group.
RT